Alumis
(NASDAQ) ALMS
Alumis Financials at a Glance
Market Cap
$2.43B
Revenue (TTM)
$8.40M
Net Income (TTM)
-$237.42M
EPS (TTM)
-$1.92
P/E Ratio
-9.92
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$19.07
Volume
55,566
Open
$20.26
Price
$19.07
Volume
55,566
Open
$20.26
Previous Close
$19.07
Daily Range
$19.07 - $20.99
52-Week Range
$2.76 - $30.60
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$19.07
Volume
55,566
Open
$20.26
Previous Close
$19.07
Daily Range
$19.07 - $20.99
52-Week Range
$2.76 - $30.60
Estimated Earnings Date
Aug 12, 2026
ALMS News
ALMS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alumis
Industry
Pharmaceuticals
Sector
Health CareEmployees
224
CEO
Martin Babler
Website
www.alumis.comHeadquarters
South San Francisco, CA 94080, US
ALMS Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-54%
Net Income Margin
-28%
Return on Equity
-65%
Return on Capital
-75%
Return on Assets
-35%
Earnings Yield
-10.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.43B
Shares Outstanding
127.49M
Volume
55.57K
Avg. Volume
1.29M
Financials (TTM)
Gross Profit
$20.55M
Operating Income
-$427.20M
EBITDA
-$423.71M
Operating Cash Flow
-$369.52M
Capital Expenditure
-$653.00K
Free Cash Flow
-$370.18M
Cash & ST Invst.
$308.50M
Total Debt
$36.91M
Alumis Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.74M
-90.0%
Gross Profit
$870.00K
-95.0%
Gross Margin
49.97%
N/A
Market Cap
$2.43B
N/A
Market Cap/Employee
$14.46M
N/A
Employees
168
N/A
Net Income
-$93.05M
+6.0%
EBITDA
-$97.54M
+3.1%
Quarterly Fundamentals
Net Cash
$487.28M
+175.5%
Accounts Receivable
$2.73M
+112.1%
Inventory
$0.00
N/A
Long Term Debt
$31.22M
+6.4%
Short Term Debt
$4.44M
+74.5%
Return on Assets
-35.35%
N/A
Return on Invested Capital
-75.03%
N/A
Free Cash Flow
-$87.25M
-8.5%
Operating Cash Flow
-$87.08M
-8.4%